Prestige Consumer Healthcare Inc. (PBH) |
| 47.74 -1.09 (-2.23%) 07-14 13:59 |
| Open: | 48.22 |
| High: | 48.24 |
| Low: | 47.2 |
| Volume: | 173,953 |
| Market Cap: | 2,262(M) |
| PE Ratio: | 10.87 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Distribution |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 50.47 |
| Resistance 1: | 48.46 |
| Pivot price: | 48.29 |
| Support 1: | 45.22 |
| Support 2: | 37.62 |
| 52w High: | 77.45 |
| 52w Low: | 42.62 |
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
| EPS | 3.910 |
| Book Value | 39.890 |
| PEG Ratio | 1.46 |
| Gross Profit | 12.791 |
| Profit Margin (%) | 17.48 |
| Operating Margin (%) | 26.81 |
| Return on Assets (ttm) | 5.6 |
| Return on Equity (ttm) | 10.2 |
Mon, 13 Jul 2026
John Rogers Increases Stake in Prestige Consumer Healthcare Inc - GuruFocus
Mon, 13 Jul 2026
Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 36.61% Potential Upside in a Competitive Market - DirectorsTalk Interviews
Thu, 09 Jul 2026
Enterprise value to revenue forward of Prestige Consumer Healthcare Inc. – NYSE:PBH - TradingView
Thu, 09 Jul 2026
Prestige Consumer (NYSE: PBH) updates filing on OTC Wellness acquisition - Stock Titan
Mon, 06 Jul 2026
Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date - Yahoo Finance
Sat, 04 Jul 2026
Prestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand Acquisition - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |